Literature DB >> 21655451

Vacuolar trafficking and Candida albicans pathogenesis.

Glen E Palmer1.   

Abstract

The vacuole is likely to play a variety of roles in supporting host colonization and infection by pathogenic species of fungi. In the human pathogen Candida albicans, the vacuole undergoes dynamic morphological shifts during the production of the tissue invasive hyphal form, and this organelle is required for virulence. Recent efforts in my lab have focused on defining which vacuolar trafficking pathways are required for C. albicans hyphal growth and pathogenesis. Our results indicate that there are several distinct trafficking routes between the Golgi apparatus and vacuole. However, there is a large degree of functional overlap between each with respect to their roles in hyphal growth and virulence. Herein we consider these results and propose that during hyphal growth, specific trafficking routes maybe less important than the aggregate vacuolar trafficking capacity.

Entities:  

Keywords:  AP-3; Candida albicans; UME6; VPS21; endosome; golgi; hyphal growth; pathogenesis; trafficking; vacuole

Year:  2011        PMID: 21655451      PMCID: PMC3104590          DOI: 10.4161/cib.4.2.14717

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  17 in total

1.  Endosomal and AP-3-dependent vacuolar trafficking routes make additive contributions to Candida albicans hyphal growth and pathogenesis.

Authors:  Glen E Palmer
Journal:  Eukaryot Cell       Date:  2010-09-24

2.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

3.  The Candida albicans vacuole is required for differentiation and efficient macrophage killing.

Authors:  G E Palmer; M N Kelly; J E Sturtevant
Journal:  Eukaryot Cell       Date:  2005-10

Review 4.  Protein transport from the late Golgi to the vacuole in the yeast Saccharomyces cerevisiae.

Authors:  Katherine Bowers; Tom H Stevens
Journal:  Biochim Biophys Acta       Date:  2005-07-10

5.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

6.  UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence.

Authors:  Mohua Banerjee; Delma S Thompson; Anna Lazzell; Patricia L Carlisle; Christopher Pierce; Carlos Monteagudo; José L López-Ribot; David Kadosh
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

7.  Role for endosomal and vacuolar GTPases in Candida albicans pathogenesis.

Authors:  Douglas A Johnston; Karen E Eberle; Joy E Sturtevant; Glen E Palmer
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

8.  Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence.

Authors:  Patricia L Carlisle; Mohua Banerjee; Anna Lazzell; Carlos Monteagudo; José L López-Ribot; David Kadosh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

9.  Candida albicans VPS11 is required for vacuole biogenesis and germ tube formation.

Authors:  Glen E Palmer; Annette Cashmore; Joy Sturtevant
Journal:  Eukaryot Cell       Date:  2003-06

Review 10.  Vacuoles and fungal biology.

Authors:  Veronica Veses; Andrea Richards; Neil A R Gow
Journal:  Curr Opin Microbiol       Date:  2008-11-03       Impact factor: 7.934

View more
  14 in total

1.  Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.

Authors:  Arturo Luna-Tapia; Morgan E Kerns; Karen E Eberle; Branko S Jursic; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

2.  Vocation, location, vocation: researching Candida pathogenesis.

Authors:  Joy Sturtevant
Journal:  Virulence       Date:  2014       Impact factor: 5.882

3.  Essential role for vacuolar acidification in Candida albicans virulence.

Authors:  Cassandra Patenaude; Yongqiang Zhang; Brendan Cormack; Julia Köhler; Rajini Rao
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 4.  Interplay between Candida albicans and the mammalian innate host defense.

Authors:  Shih-Chin Cheng; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

5.  Deletion of vacuolar proton-translocating ATPase V(o)a isoforms clarifies the role of vacuolar pH as a determinant of virulence-associated traits in Candida albicans.

Authors:  Summer M Raines; Hallie S Rane; Stella M Bernardo; Jessica L Binder; Samuel A Lee; Karlett J Parra
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

6.  Three prevacuolar compartment Rab GTPases impact Candida albicans hyphal growth.

Authors:  Douglas A Johnston; Arturo Luna Tapia; Karen E Eberle; Glen E Palmer
Journal:  Eukaryot Cell       Date:  2013-05-24

7.  Candida albicans VMA3 is necessary for V-ATPase assembly and function and contributes to secretion and filamentation.

Authors:  Hallie S Rane; Stella M Bernardo; Summer M Raines; Jessica L Binder; Karlett J Parra; Samuel A Lee
Journal:  Eukaryot Cell       Date:  2013-08-02

8.  Intracellular aspartic proteinase Apr1p of Candida albicans is required for morphological transition under nitrogen-limited conditions but not for macrophage killing.

Authors:  Václava Bauerová; Miroslav Hájek; Iva Pichová; Olga Hrušková-Heidingsfeldová
Journal:  Folia Microbiol (Praha)       Date:  2014-06-01       Impact factor: 2.099

Review 9.  Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

10.  Gymnemic acids inhibit hyphal growth and virulence in Candida albicans.

Authors:  Govindsamy Vediyappan; Vincent Dumontet; Franck Pelissier; Christophe d'Enfert
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.